ARHGEF15: A Protein Involved in Cellular Signaling, Cardiovascular Function and Kidney Function

Target Name: ARHGEF15

NCBI ID: G22899

ARHGEF15: A Protein Involved in Cellular Signaling, Cardiovascular Function and Kidney Function

ARHGEF15 (MGC44868) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling.

ARHGEF15 is a 19-kDa protein that is expressed in the brain, heart, and kidneys. It is highly conserved, with a calculated pI of 4.87. The protein is composed of a N-terminal extracellular domain, a transmembrane domain, and an C -terminal intracellular domain. The N-terminal and C-terminal domains contain putative GPCR-related functional domains, such as an N-terminal alpha-helix and a C-terminal gamma-sheet, respectively.

The transmembrane domain of ARHGEF15 is a unique feature that is found in many GPCR proteins. It is composed of a series of parallel beta-sheets that are held together by hydrogen bonding and other non-covalent interactions. This structural arrangement allows the transmembrane domain to interact with various signaling molecules, including G proteins, phosphatidylinositol (PIP), and other GPCR-related proteins.

ARHGEF15 is a protein that is involved in a variety of physiological processes in the body. One of its primary functions is to regulate the activity of other GPCR proteins. It is thought to play a role in the regulation of neural plasticity, which is the ability of the brain to change and adapt over time.

ARHGEF15 is also involved in the regulation of cardiovascular function. It is thought to play a role in the regulation of heart rate and blood pressure, and is expressed in the heart and blood vessels.

ARHGEF15 is also involved in the regulation of kidney function. It is thought to play a role in the regulation of urine output and the maintenance of normal kidney function.

In addition to its involvement in cellular signaling, ARHGEF15 is also a potential drug target. Several studies have suggested that ARHGEF15 may be a useful target for the development of new therapies for various diseases, including cardiovascular disease, neurodegenerative diseases, and kidney disease.

One way to target ARHGEF15 is through the use of small molecules that can modulate its activity. For example, several studies have shown that inhibitors of the GPCR signaling pathway, which includes ARHGEF15, can be effective in treating neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Another approach to targeting ARHGEF15 is through the use of antibodies that can specifically recognize and label it. This approach has been used to study the molecular mechanisms of ARHGEF15 function, as well as to test its potential as a drug target.

Overall, ARHGEF15 is a protein that is involved in a variety of physiological processes in the body. It is a member of the GPCR family and is thought to play a key role in the regulation of cellular signaling, cardiovascular function, and kidney function. As a result, it is a potential drug target for the development of new therapies for various diseases.

Protein Name: Rho Guanine Nucleotide Exchange Factor 15

Functions: Specific GEF for RhoA activation. Does not activate RAC1 or CDC42. Regulates vascular smooth muscle contractility. Negatively regulates excitatory synapse development by suppressing the synapse-promoting activity of EPHB2

More Common Targets